Skip Navigation



NDT Plus Advance Access published online on June 23, 2008
NDT Plus, doi:10.1093/ndtplus/sfn090
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Teutonico, A.
Right arrow Articles by Basile, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Treatment of metformin-associated lactic acidosis with sustained low-efficiency daily dialysis

Annalisa Teutonico1, Pasquale Libutti1, Carlo Lomonte1, Maurizio Antonelli1, Francesco Casucci1 and Carlo Basile2

1 Division of Nephrology Miulli General Hospital
2 UOC Nefrologia, Ospedale Generale Miulli, Acquaviva delle Fonti, Italy

Correspondence: E-mail: basile.miulli@libero.it

The first 10% of the full text of this article appears below.

Sir,

Sustained low-efficiency daily dialysis (SLEDD) is an intermittent prolonged dialysis modality which is increasingly used for the treatment of acute renal failure [1,2], as it combines most of the advantages of both the classic intermittent treatments and the continuous modalities in terms of safety, efficacy, haemodynamic stability and costs. GENIUS® 90 Therapy System (GENIUS) (Fresenius Medical Care, Bad Homburg, Germany) gained interest for . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?